Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist supplied in a convenient 10-vial research kit, with each vial containing 5mg of lyophilized peptide. Widely utilized in laboratory studies, Tirzepatide is researched for its role in glucose metabolism, appetite regulation, and metabolic signaling pathways. Manufactured to high purity standards, each vial is designed to provide consistency and reliability for scientific research applications.
For research use only. Not intended for human consumption, medical use, or therapeutic purposes.